DOI:
10.1055/s-00000089
Ultraschall in der Medizin - European Journal of Ultrasound
LinksClose Window
References
Trouilloud I, Dupont-Gossard AC, Malka D. et al.
Fixed-dose rate gemcitabine alone or alternating with FOLFIRI.3 (irinotecan, leucovorin and fluorouracil) in the first-line treatment of patients with metastatic pancreatic adenocarcinoma: an AGEO randomised phase II study (FIRGEM).
European journal of cancer 2014;
50: 3116-3124
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.